Navigation Links
Global Technologies, Ltd. Announces LOI to Acquire and Merge with Oxygen Orchard, Inc.
Date:6/24/2011

ORCHARD, Texas, June 24, 2011 /PRNewswire/ -- Global Technologies, Ltd. (GTLL), announced today that it has executed a Letter of Intent to acquire and merge with Oxygen Orchard, Inc.

GTLL will acquire 100% of Oxygen Orchard and migrate all its operations to the new entity.  All current management, board, and officers will concurrently resign with execution of the various Definitive Agreements. The Definitive Agreements are expected to be completed within 21 days.

Complete disclosures and updated financials will be posted to the OTC Disclosure Service.

Teri H. Mathis, President and CEO of Oxygen Orchard, Inc., will be the new President and CEO. John M. King will be the new CFO.

The Company will change its name to Oxygen Orchard, Inc.

The Company will release additional announcements describing products, markets, and revenue plans.

About Oxygen Orchard, Inc. (formerly Global Technologies):

Oxygen Orchard, Inc. specializes in the design, manufacture and sale of its patented water oxygenating system. The Company is the industry leader in its product category. Based on medical research and market results, the Company's products provide supplemental oxygen to users, resulting in ailment prevention and enhancement of overall wellness. Oxygen Orchard is a woman-owned business and is currently expanding its operations and product distribution internationally.

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the Safe Harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from the expected results.

Contact:
Oxygen Orchard, Inc.
P.O. Drawer A
Orchard, TX 77464
Phone: 713-446-5337
Toll Free: 877-347-7770
Email: invest@oxygenorchard.com
Website: www.oxygenorchard.com


'/>"/>
SOURCE Global Technologies, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elseviers SciVal Funding Expands Globally
2. Reportlinker Adds Global CRO Market: Quantitative Assessment
3. Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
4. Ashoka and Boehringer Ingelheim Announce a Global Partnership for "Making More Health"
5. Flextronics Global Services Budapest Receives ISO 13485 Medical Certification
6. Boston Scientific Announces Global Launch of Mustang™ PTA Balloon Catheter
7. Panacea Global, Inc. Files Form 8-K to Announce Name Change; Trading Symbol Changes from MLXG to PANG
8. Reportlinker Adds Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
9. Reportlinker Adds Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
10. Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
11. Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology:
(Date:6/27/2017)... , ... June 27, 2017 , ... Hammer Strength, the ... (NBSCA) have named Javair Gillett of the Houston Rockets the NBSCA Strength & Conditioning ... award is decided by NBSCA members who vote to select the coach who embodies ...
(Date:6/27/2017)... ... June 27, 2017 , ... East Los Angeles dentist, Ramin ... about early life experiences. What happens to a woman during pregnancy can have profound ... can also take a toll on a baby’s long-term health. This study, which was ...
(Date:6/26/2017)... ... ... Dental Center is now offering various types of dental implants to restore lost teeth. ... prosthetic teeth, such as crowns, bridges, or dentures. An implant is placed directly into the ... for the tooth. , Several types of dental implants are available, including: , ...
(Date:6/26/2017)... ... June 26, 2017 , ... Maryland’s soybean farmers have improved ... released by the United Soybean Board. , Thanks to the responsible use ... their productivity on less land per bushel, the report says. The United Soybean ...
(Date:6/26/2017)... ... June 26, 2017 , ... If ... are seeing lots of red these days. According to recent estimates, 75 – ... from medical coding errors(1). Some studies point to Electronic Health Records (EHR) with ...
Breaking Medicine News(10 mins):